SEC Form 4 · accession 0001144204-15-024291
VACCINOGEN INC · VGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Hakan Edstrom
Director
Period of report
Apr 20, 2015
Accepted (ET)
Apr 22, 2015 · 3:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001453001
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 20, 2015 | A | 1,341 | $0.00 | A | 1,341 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock options (right to buy)F1 | $3.90 | Apr 20, 2015 | A | 33,750 | A | — | Apr 20, 2025 | Common stock | 33,750 | 33,750 | D |
Explanation of responses
- F1The option becomes exercisable in three equal installments on April 20, 2016, 2017, and 2018.